Cargando…

Multidimensional biomarkers for multiple system atrophy: an update and future directions

Multiple system atrophy (MSA) is a fatal progressive neurodegenerative disease. Biomarkers are urgently required for MSA to improve the diagnostic and prognostic accuracy in clinic and facilitate the development and monitoring of disease-modifying therapies. In recent years, significant research eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Linlin, Zhu, Sudan, Chen, Zhao, Qiu, Rong, Tang, Beisha, Jiang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375766/ https://www.ncbi.nlm.nih.gov/pubmed/37501056 http://dx.doi.org/10.1186/s40035-023-00370-0

Ejemplares similares

Serum vitamin levels in multiple system atrophy: A case-control study
por: Chen, Daji, et al.
Publicado: (2023)

Alterations of the Gut Microbiota in Multiple System Atrophy Patients
por: Wan, Linlin, et al.
Publicado: (2019)

Corrigendum: Alterations of the Gut Microbiota in Multiple System Atrophy Patients
por: Wan, Linlin, et al.
Publicado: (2020)

Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study
por: Chen, Dan, et al.
Publicado: (2015)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Heterogeneity of Multiple System Atrophy: An Update
por: Jellinger, Kurt A.
Publicado: (2022)

MR Imaging of SCA3/MJD
por: Wan, Na, et al.
Publicado: (2020)

Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease
por: Sun, Zhanfang, et al.
Publicado: (2016)

Roles of Post-translational Modifications in Spinocerebellar Ataxias
por: Wan, Linlin, et al.
Publicado: (2018)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Multidimensional impact of COVID-19 pandemic in India—Challenges and future direction
por: Kumar, Rajesh, et al.
Publicado: (2020)

Baseline biomarkers of connectome disruption and atrophy predict future processing speed in early multiple sclerosis
por: Kuceyeski, A., et al.
Publicado: (2018)

Multidetector CT Imaging Biomarkers as Predictors of Prognosis in Shock: Updates and Future Directions
por: Valente, Tullio, et al.
Publicado: (2023)

An update on advances in magnetic resonance imaging of multiple system atrophy
por: Chelban, Viorica, et al.
Publicado: (2018)

Update on heart failure management and future directions
por: Choi, Hong-Mi, et al.
Publicado: (2019)

Update on heart failure management and future directions
por: Choi, Hong-Mi, et al.
Publicado: (2019)

Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy
por: Binz, Camilla, et al.
Publicado: (2022)

Anxiety and depression in spinocerebellar ataxia patients during the COVID-19 pandemic in China: A cross-sectional study
por: Gong, Yiqing, et al.
Publicado: (2021)

Crossed cerebellar atrophy: Update
por: Jiménez-Caballero, Pedro E
Publicado: (2012)

Dentatorubral-pallidoluysian Atrophy: An Update
por: Carroll, Liam S., et al.
Publicado: (2018)

Keloids and Hypertrophic Scars: Update and Future Directions
por: Huang, Chenyu, et al.
Publicado: (2013)

Global Updates on the Future Directions of Neurotoxins and Fillers
por: Downie, Jeanine B., et al.
Publicado: (2016)

Review: Oncolytic virotherapy, updates and future directions
por: Fountzilas, Christos, et al.
Publicado: (2017)

An update on migraine: current understanding and future directions
por: Puledda, Francesca, et al.
Publicado: (2017)

Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2019)

Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy
por: Zheng, Yuanchu, et al.
Publicado: (2022)

Update on alternative therapies for vulvovaginal atrophy
por: Chollet, Janet A
Publicado: (2011)

Polyglutamine-expanded ataxin3 alter specific gene expressions through changing DNA methylation status in SCA3/MJD
por: Ding, Dongxue, et al.
Publicado: (2020)

Context value updating and multidimensional neuronal encoding in the retrosplenial cortex
por: Sun, Weilun, et al.
Publicado: (2021)

RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China
por: Li, Tianjiao, et al.
Publicado: (2019)

Virus Variation Resource—recent updates and future directions
por: Brister, J. Rodney, et al.
Publicado: (2014)

Small cell lung cancer: updates and future directions
por: Pacheco, Jose M.
Publicado: (2020)

Dermatology COVID-19 Registries: Updates and Future Directions
por: Freeman, Esther E., et al.
Publicado: (2021)

Current update and future directions on gut microbiome and nephrolithiasis
por: Sharma, Ajay P., et al.
Publicado: (2020)

Regulatory Effects of Curcumin on Platelets: An Update and Future Directions
por: Hussain, Yaseen, et al.
Publicado: (2022)

PET Imaging in Bladder Cancer: An Update and Future Direction
por: Zhang-Yin, Jules, et al.
Publicado: (2023)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
por: Gandor, Florin, et al.
Publicado: (2020)

Biomarkers for Temporomandibular Disorders: Current Status and Future Directions
por: Zwiri, Abdalwhab, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h1f7et0pl6btfduvmqr0djopuq